While in the presence of 100 nM insulin, crocetin showed a synergistic Akt phosphorylation-improving effect, suggesting that crocetin might be an insulin-sensitizing agent to treat type 2 diabetes. Here, AKT1 is linked to type 2 diabetes mellitus.